Panos Douvaras, PhD
Associate Director at BlueRock Therapeutics
2014 NYSCF – Druckenmiller Fellow Alumnus
PhD, Edinburgh University
Dr. Douvaras used human embryonic and induced pluripotent stem cells to model the defects and identify possible treatments for multiple sclerosis. He had joined NYSCF after completing post-doctoral research at Mount Sinai School of Medicine studying hematopoiesis and the induction of pluripotency in primitive erythrocytes.